EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A case report of HER2-positive descending colon cancer with peritoneal metastasis and literature review

Yaochun Lv, Zhengpeng Qian, Dewang Wu, Chengzhang Zhu, Jipeng Zhang, Yeping Ning, Binbin Du

Frontiers in Oncology · 14.03.2025 · 15

DOI: 10.3389/fonc.2025.1473620 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 14.03.2025. Verfasst von Yaochun Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gansu Clinical Medical Research Center for Anorectal Diseases, Lanzhou, Gansu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province, Lanzhou Science and Technology Bureau, Science and Technology Program of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human epidermal growth factor receptor 2 (HER2) is an anti-cancer drug target for colon cancer. Among patients with colorectal malignancy (colorectal cancer, CRC), those with HER2 mutations have a poor overall prognosis and a significantly increased drug resistance. In recent years, anti-HER2 therapeutic drugs have developed rapidly. According to several clinical studies and case reports, anti-HER2 therapy, as an emerging anti-cancer approach, plays a crucial role in the treatment of HER2-positive CRC patients. Here, we present a case of HER2-positive descending colon cancer with peritoneal metastasis. The patient is a 26-year-old male, diagnosed with malignant tumor of the descending colon with peritoneal metastasis in April 2020. After multiple treatment modalities, the disease progressed. After chemotherapy with Trastuzumab Deruxtecan (T-DXd/DS-8201), the metastatic foci significantly shrank, and after surgical resection, a tumor-free state (NED) was achieved. Up to now, the patient’s survival period has reached 56 months.

Schlagwörter

Stichwörter der Autor:innen

HER2-positive descending colon canceranti-HER2 therapycase reportmultidisciplinary collaboration (MDT)peritoneal metastasis

Autor:innen und Institutionen

  • Gansu Clinical Medical Research Center for Anorectal Diseases, Lanzhou, Gansu, China.
  • The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
  • Clinical Medical Research Center for Anorectal Diseases of Gansu Province, Gansu Provincial Hospital, Lanzhou, China.
  • The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.

Förderung

  • Natural Science Foundation of Gansu Province
  • Lanzhou Science and Technology Bureau
  • Science and Technology Program of Gansu Province

Zitieren

APA

Lv, Y., Qian, Z., Wu, D., Zhu, C., Zhang, J., Ning, Y., & Du, B. (2025). A case report of HER2-positive descending colon cancer with peritoneal metastasis and literature review. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1473620

Vancouver

Lv Y, Qian Z, Wu D, Zhu C, Zhang J, Ning Y, et al. A case report of HER2-positive descending colon cancer with peritoneal metastasis and literature review. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1473620

BibTeX
@article{Lv2025,
  author = {Lv, Yaochun and Qian, Zhengpeng and Wu, Dewang and Zhu, Chengzhang and Zhang, Jipeng and Ning, Yeping and Du, Binbin},
  title = {A case report of HER2-positive descending colon cancer with peritoneal metastasis and literature review},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1473620}
}
Kostenlos starten →